Nathan Guz
Plus aucun poste en cours
Profil
Nathan Guz worked as a Senior Director-Chemical Development at Global Blood Therapeutics, Inc. and as a Vice President-Technical Operations at Unity Biotechnology, Inc. He holds a doctorate degree from Colorado State University.
Anciens postes connus de Nathan Guz
| Sociétés | Poste | Fin |
|---|---|---|
| GLOBAL BLOOD THERAPEUTICS, INC. | Corporate Officer/Principal | - |
| UNITY BIOTECHNOLOGY, INC. | Chief Operating Officer | - |
Formation de Nathan Guz
| Colorado State University | Doctorate Degree |
Expériences
Fonctions occupées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| UNITY BIOTECHNOLOGY, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Global Blood Therapeutics, Inc.
 Global Blood Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. It also provides oral medicines for sickle cell diseases. The company was founded by Matthew P. Jacobson, Andrej Sali, Jack Taunton, Charles J. Homcy, Craig D. Muir, and David R. Phillips in February 2011 and is headquartered in South San Francisco, CA. | Health Technology |
